Determinación experimental del equilibrio líquido-liquido de mezclas binarias fenilacetona + alcano

La fenilacetona es un precursor de la anfetamina y metanfetamina, potentes estimulantes del sistema nervioso central y utilizadas como drogas de “diseño”. Además, la fenilacetona es el producto de la desaminación de la anfetamina en el cuerpo humano. Por otra parte, el estudio de mezclas que contienen un compuesto aromático con un grupo funcional polar permite investigar una serie de efectos tales como interacciones intramoleculares entre el anillo bencénico y un grupo funcional polar (interacciones n- π). En este trabajo se han determinado las curvas de los equilibrios líquido-líquido de mezclas binarias formadas por fenilacetona + CH3(CH2)uCH3 (u = 8,12,14) mediante el método de la opalescencia crítica utilizando un sistema de dispersión de luz láser durante la transición. Todos los sistemas muestran una temperatura de solución crítica superior (UCST), que aumenta casi linealmente con la longitud del n-alcano, u

Determinación experimental del equilibrio sólido líquido mediante DSC

Aunque las aplicaciones más importantes del estudio del equilibrio sólido-líquido están en el campo de la metalurgia y la mineralogía, la información que puede aportar este estudio resulta también de gran aplicabilidad en el área de la fabricación de alimentos y productos farmacéuticos, cosmética y el almacenamiento energético con los materiales de cambio de fase (PCM’s). Sin embargo, tal vez es de los procesos de cambio de fase, el que ha suscitado menos atención. Convencionalmente, los datos de equilibrio sólido-líquido se han determinado mediante técnicas de enfriamiento estático, procedimientos largos y muy laboriosos si se pretenden obtener diagramas precisos. Alternativas más actuales son las técnicas de análisis térmico diferencial (DTA) y la calorimetría diferencial de barrido (DSC), que reducen considerablemente el tiempo de experimentación y aumentan la precisión de las medidas[1]. En este trabajo se describe la puesta a punto de un sistema DSC para la determinación del equilibrio sólido-líquido de sistemas binarios. Para determinar la bondad del equipo se utiliza como sistema test el sistema ciclohexano-benceno[2], sistema del que, además del diagrama de fases, se determina la composición del eutéctico. Validada la técnica experimental, se procede al estudio del equilibrio sólido-líquido de sistemas binarios formados por ciclohexilamina + alcanos

Thermodynamics of amide + amine mixtures. 5. Excess molar enthalpies of N,N-dimethylformamide or N,N-dimethylacetamide + N-propylpropan-1-amine, + N-butylbutan-1-amine, + butan-1-amine, or + hexan-1-amine systems at 298.15 K. Application of the ERAS model

Producción CientíficaExcess molar enthalpies, HEm, over the whole composition range have been determined for the liquid mixtures N,N-dimethylformamide (DMF) or N,N-dimethylacetamide (DMA) + butan-1-amine (BA), or + hexan-1-amine (HxA), or + N-propylpropan-1-amine (DPA), or N-butylbutan-1-amine (DBA) at 298.15 K and at 0.1 MPa using a BT2.15 calorimeter from Setaram adapted to work in dynamic mode at constant temperature and pressure. All the HEm values are positive, indicating that interactions between like molecules are predominant. The replacement of DMF by DMA in systems with a given amine leads to lower HEm results, which have been ascribed to stronger amide-amide interactions in DMF mixtures. The replacement of HxA by DPA in systems with a given amide leads to slightly higher HEm values, as interactions between unlike molecules are weaker for the latter. Structural effects in the investigated solutions are also present, since the corresponding excess molar volumes (VEm), previously determined, are negative or slightly positive. The systems have been characterized in terms of the ERAS model reporting the interaction parameters. The model correctly describes both HEm and VEm. The application of the model suggests that, in the systems under study, solvation effects are of minor importance and that physical interactions are dominant.Consejería de Educación, Junta de Castilla y León: Project VA100G19 (Apoyo a GIR, BDNS: 425389)Ministerio de Educación, Cultura y Deporte (MECD): Grant FPU14/04104Ministerio de Educación, Cultura y Deporte (MECD): Complementary Grants EST16/00824 and EST17/0029

The Radiative Transfer Equation inversion on FPGA. the case of the Photospheric Magnetic field Imager

Part of the Proceedings of the 2023 European Data Handling and Data Processing Conference for Space (EDHPC 2023) Juan-Les-Pins2 October 2023 through 6 October 2023. Code 196870We present the radiative transfer equation (RTE) inverter core, a high performance SIMD architecture, to interpret the data obtained by the Polarimetric and Magnetic field Imager (PMI) instrument aboard the ESA's Vigil mission. After some pre-processing, the spectropolarimetric data will be translated on board into physical quantities of the solar atmosphere to be directly downloaded to Earth, hence strongly reducing the telemetry needs of such a deep space mission. The RTE inverter is direct heritage from that in the Polarimetric and Helioseismic Imager (PHI) aboard the ESA/NASA's Solar Orbiter mission. The more stringent requirements of Vigil as compared to Solar Orbiter, as well as the production discontinuation of the FPGA used in the PHI instrument, have driven the migration of the inverter architecture to a brand-new, more powerful FPGA device (Xilinx Kintex UltraScale XQRKU060). © 2023 ESA.ACKNOWLEDGMENTS This work has been funded by AEI/MCIN/10.13039/ 501100011033/ (RTI2018-096886-C5, PID2021-125325OB-C5, PCI2022-135009-2) and ERDF “A way of making Europe”; “Center of Excellence Severo Ochoa” awards to IAA-CSIC (SEV-2017-0709, CEX2021-001131-S); and a Ramón y Cajal fellowship awarded to DOS

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.

Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex trait with a polygenic component that is mainly unidentified. We propose that levels of intermediate molecular phenotypes (IMPs) in the myocardium associated with histopathological damage could explain CDA susceptibility, so variants of genes encoding these IMPs could identify patients susceptible to this complication. Thus, a genetically heterogeneous cohort of mice (n = 165) generated by backcrossing were treated with doxorubicin and docetaxel. We quantified heart fibrosis using an Ariol slide scanner and intramyocardial levels of IMPs using multiplex bead arrays and QPCR. We identified quantitative trait loci linked to IMPs (ipQTLs) and cdaQTLs via linkage analysis. In three cancer patient cohorts, CDA was quantified using echocardiography or Cardiac Magnetic Resonance. CDA behaves as a complex trait in the mouse cohort. IMP levels in the myocardium were associated with CDA. ipQTLs integrated into genetic models with cdaQTLs account for more CDA phenotypic variation than that explained by cda-QTLs alone. Allelic forms of genes encoding IMPs associated with CDA in mice, including AKT1, MAPK14, MAPK8, STAT3, CAS3, and TP53, are genetic determinants of CDA in patients. Two genetic risk scores for pediatric patients (n = 71) and women with breast cancer (n = 420) were generated using machine-learning Least Absolute Shrinkage and Selection Operator (LASSO) regression. Thus, IMPs associated with heart damage identify genetic markers of CDA risk, thereby allowing more personalized patient management.J.P.L.’s lab is sponsored by Grant PID2020-118527RB-I00 funded by MCIN/AEI/10.13039/ 501100011039; Grant PDC2021-121735-I00 funded by MCIN/AEI/10.13039/501100011039 and by the “European Union Next Generation EU/PRTR”, the Regional Government of Castile and León (CSI144P20). J.P.L. and P.L.S. are supported by the Carlos III Health Institute (PIE14/00066). AGN laboratory and human patients’ studies are supported by an ISCIII project grant (PI18/01242). The Human Genotyping unit is a member of CeGen, PRB3, and is supported by grant PT17/0019 of the PE I + D + i 2013–2016, funded by ISCIII and ERDF. SCLl is supported by MINECO/FEDER research grants (RTI2018-094130-B-100). CH was supported by the Department of Defense (DoD) BCRP, No. BC190820; and the National Cancer Institute (NCI) at the National Institutes of Health (NIH), No. R01CA184476. Lawrence Berkeley National Laboratory (LBNL) is a multi-program national laboratory operated by the University of California for the DOE under contract DE AC02-05CH11231. The Proteomics Unit belongs to ProteoRed, PRB3-ISCIII, supported by grant PT17/0019/0023 of the PE I + D +i, 2017–2020, funded by ISCIII and FEDER. RCC is funded by fellowships from the Spanish Regional Government of Castile and León. NGS is a recipient of an FPU fellowship (MINECO/FEDER). hiPSC-CM studies were funded in part by the “la Caixa” Banking Foundation under the project code HR18-00304 and a Severo Ochoa CNIC Intramural Project (Exp. 12-2016 IGP) to J.J.S

Autonomous on-board data processing and instrument calibration software for the Polarimetric and Helioseismic Imager on-board the Solar Orbiter mission

This is an open access article. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.A frequent problem arising for deep space missions is the discrepancy between the amount of data desired to be transmitted to the ground and the available telemetry bandwidth. A part of these data consists of scientific observations, being complemented by calibration data to help remove instrumental effects. We present our solution for this discrepancy, implemented for the Polarimetric and Helioseismic Imager on-board the Solar Orbiter mission, the first solar spectropolarimeter in deep space. We implemented an on-board data reduction system that processes calibration data, applies them to the raw science observables, and derives science-ready physical parameters. This process reduces the raw data for a single measurement from 24 images to five, thus reducing the amount of downlinked data, and in addition, renders the transmission of the calibration data unnecessary. Both these on-board actions are completed autonomously. © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.This work was carried out in the framework of the International Max Planck Research School for Solar System Science at the Max Planck Institute for Solar System Research. Solar Orbiter is a mission led by the European Space Agency with contribution from the National Aeronautics and Space Administration (NASA). The Polarimetric and Helioseismic Imager instrument is supported by the German Aerospace Center (DLR) under grant Nos. 50 OT 1201 and 50 OT 1901. The Spanish contribution has been partly funded by the Spanish Research Agency under projects under grant Nos. ESP2016-77548-C5 and RTI2018-096886-B-C5, partially including European FEDER funds. IAA-CSIC members acknowledge and funds from the Spanish Ministry of Science and Innovation “Centro de Excelencia Severo Ochoa” Program under grant No. SEV-2017-0709. The solar data used in the tests are the courtesy of NASA/SDO HMI science team. Parts of the work shown in this paper have been introduced at the SPIE Astronomical Telescopes + Instrumentation conference.42 EditorialPeer reviewe

Role of age and comorbidities in mortality of patients with infective endocarditis

[Purpose]: The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. [Methods]: Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups:<65 years,65 to 80 years,and ≥ 80 years.The area under the receiver-operating characteristic (AUROC) curve was calculated to quantify the diagnostic accuracy of the CCI to predict mortality risk. [Results]: A total of 3120 patients with IE (1327 < 65 years;1291 65-80 years;502 ≥ 80 years) were enrolled.Fever and heart failure were the most common presentations of IE, with no differences among age groups.Patients ≥80 years who underwent surgery were significantly lower compared with other age groups (14.3%,65 years; 20.5%,65-79 years; 31.3%,≥80 years). In-hospital mortality was lower in the <65-year group (20.3%,<65 years;30.1%,65-79 years;34.7%,≥80 years;p < 0.001) as well as 1-year mortality (3.2%, <65 years; 5.5%, 65-80 years;7.6%,≥80 years; p = 0.003).Independent predictors of mortality were age ≥ 80 years (hazard ratio [HR]:2.78;95% confidence interval [CI]:2.32–3.34), CCI ≥ 3 (HR:1.62; 95% CI:1.39–1.88),and non-performed surgery (HR:1.64;95% CI:11.16–1.58).When the three age groups were compared,the AUROC curve for CCI was significantly larger for patients aged <65 years(p < 0.001) for both in-hospital and 1-year mortality. [Conclusion]: There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in the <65-year group

Anafilaxia en niños y adultos: prevención, diagnóstico y tratamiento

La anafilaxia es una condición que requiere asistencia inmediata para su resolución, se puede presentar en diferentes entornos: consultorio, hospital, escuela, hogar o en algún otro espacio público. La información aquí contenida forma parte de lineamientos conocidos sobre prevención, diagnóstico y tratamiento. Se abordan aspectos epidemiológicos, desencadenantes, factores de riesgo y cofactores; se explican de una manera didáctica los mecanismos fisiopatológicos que se traducen en fenotipos de presentación. Se enfatiza el diagnóstico clínico con base en criterios ya establecidos, se mencionan clasificaciones para evaluar la gravedad de la reacción, así como el rol de las pruebas clínicas o de laboratorio. Como aspectos de relevancia, se abordan el tratamiento de primera elección con adrenalina, instrucciones sobre autoinyectores y diferentes elementos para el tratamiento complementario y de segunda elección. También se refieren aspectos a considerar al dar de alta a un paciente y medidas de seguimiento, con un énfasis preventivo en la comunidad. Finalmente, se menciona el abordaje en el consultorio de alergia para decidir sobre opciones de inmunomodulación. ABSTRACT Anaphylaxis is a condition that requires immediate assistance for its resolution, it can occur in different settings: office, hospital, school, home or some other public space. The information contained herein forms part of known guidelines on prevention, diagnosis and treatment. Epidemiological aspects, triggers, risk factors and co-factors are addressed; physiopathological mechanisms that are translated into presentation phenotypes are explained in a didactic way. Clinical diagnosis is emphasized based on established criteria, classifications are mentioned to evaluate the severity of the reaction, as well as the role of clinical or laboratory tests. As relevant aspects, the first choice treatment with adrenaline, instructions on auto-injectors and different elements for the complementary and second choice treatment are dealt with. They also refer to aspects to consider when discharging a patient and followup measures, with a preventive emphasis on the community. Finally, the allergy clinic approach to deciding on immunomodulation options is mentione